Response to rituximab in a child with neuroblastoma and opsoclonus-myoclonus

Pediatric Blood and Cancer

Volumn 50, Issue 2, 2008, Pages 370-371

  Bell, Jessica ^a   Moran, Cassandra ^a   Blatt, Julie ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Neuroblastoma; Opsoclonus myoclonus; Rituximab

Indexed keywords

DIPHENHYDRAMINE; HYDROCORTISONE; IMMUNOGLOBULIN; PREDNISONE; RITUXIMAB;

ARTICLE; ATAXIA; CASE REPORT; CHILD BEHAVIOR; CHILD DEVELOPMENT; CHROMOSOME 12Q; CHROMOSOME 5Q; CHROMOSOME TRANSLOCATION 12; CHROMOSOME TRANSLOCATION 5; CYTOGENETICS; FEMALE; HUMAN; MOTOR PERFORMANCE; NEUROBLASTOMA; OPSOCLONUS MYOCLONUS SYNDROME; PREMEDICATION; PRESCHOOL CHILD; PRIORITY JOURNAL; TREATMENT OUTCOME; WALKING;

ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS; CHILD, PRESCHOOL; FEMALE; HUMANS; IMMUNOLOGIC FACTORS; INFANT; NEUROBLASTOMA; OPSOCLONUS-MYOCLONUS SYNDROME;

EID: 37549034676     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.20899     Document Type: Article

References (18)

1. Fisher PG, Wechsler DS, Singer HS. Anti-Hu antibodies in a neuroblastoma-associated paraneoplastic syndrome. Pediatr Neurol 1994;10:309-312.
2. Antunues NL, Khakoo Y, Matthay KK, et al. Antineuronal antibodies in patients with neuroblastoma and paraneoplastic opsoclonus-myoclonus. J Pediatr Hematol Oncol 2000;22:315-320.
3. Pranzatelli MR, Chun KY, Moxness M, et al. Cerebrospinal fluid ACTH and Cortisol in opsoclonus-myoclonus: Effect of therapy. Pediatr Neurol 2005;33:121-126.
4. Veneselli E, Conte M, Biancheri R, et al. Effect of steroid and high-dose immunoglobulin therapy on opsoclonus-myoclonus syndrome occurring in neuroblastoma. Med Pediatr Oncol 1998; 30:15-17.
5. Yiu WY, Kovithavongs T, McGonigle LF, et al. Plasmapheresis as an effective treatment for opsoclonus-myoclonus syndrome. Pediatr Neurol 2000;24:72-74.
6. Pranzatelli MR, Tate ED, Travelstead AL, et al. Immunologic and clinical responses to rituximab in a child with opsoclonus-myoclonus syndrome. Pediatrics 2005;115:e115-119.
7. Hayward K, Jeremy RJ, Jenkins S, et al. Long-term neurobehavioral outcomes in children with neuroblastoma and opsoclonus-myoclonus-ataxia syndrome: Relationship to MRI findings and anti-neuronal antibodies. J Pediatr 2001;139:552-559.
8. Mitchell WG, Brumm VL, Azen CG, et al. Longitudinal neurodevelopmental evaluation of children with opsoclonus-ataxia. Pediatrics 2005;116:901-907.
9. Russo C, Cohn SL, Petruzzi MJ, et al. Long-term neurologic outcome in children with opsoclonus-myoclonus associated with neuroblastoma: A report from the Pediatric Oncology Group. Med Pediatr Oncol 1997;29:284-288.
10. Furneaux HM, Rosenblum MK, Dalmau J, et al. Selective expression of Purkinje-cell antigens in tumor tissue from patients with paraneoplastic cerebellar degeneration. N Engl J Med 1990; 322:1844-1851.
11. Moretti R, Torre P, Antonello RM, et al. Opsoclonus-myoclonus ataxia syndrome: Gabapentin as a new therapeutic proposal. Eur J Neurol 2000;7:455-456.
12. Binstadt BA, Caldas AMC, Turvey SE, et al. Rituximab therapy for multisystem autoimmune disease in pediatric patients. J Pediatr 2003;143:598-604.
13. Pranzatelli MR, Travelstead AL, Tate ED, et al. B- and T-cell markers in opsoclonus-myoclonus syndrome, immunophenotyping of CSF lymphocytes. Neurology 2004;62:1526-1532.
14. Wilfong AA, Parke JT, McCrary JA. Opsoclonus-myoclonus with Beckwith-Wiedemann syndrome and hepatoblastoma. Pediatr Neurol 1992;8:77-79.
15. Rojas-Marcos I, Rousseau A, Keime-Guibert F, et al. Spectrum of paraneoplastic neurologic disorders in women with breast and gynecologic cancer. Medicine (Baltimore) 2003;82:216-223.
16. Berger JR, Mehari E, Paraneoplastic opsoclonus secondary to malignant melanoma. J Neurooncol 1999;41:43-45.
17. Kumar A, Lajara-Nanson WA, Neilson RW, Jr. Paraneoplastic opsoclonus-myoclonus syndrome: Initial presentation of non-Hodgkin's lymphoma. J Neurooncol 2005;73:43-45.
18. Kay CL, Davies-Jones GA, Singal R, et al. Paraneoplastic opsoclonus-myoclonus in Hodgkin's disease. J Neurol Neurosurg Psychiatry 1993;56:831-832.